Postdiagnostic pretreatment risk stratification for chondrosarcoma survival using routinely available registry variables: a SEER-based temporal validation study
Researchers developed and validated a risk-stratification framework for predicting survival outcomes in chondrosarcoma patients using registry data. The study demonstrates that specific clinical variables can effectively categorize patients into high-risk groups.
Why it matters
Improving prognostic accuracy for rare cancers like chondrosarcoma helps clinicians tailor treatment plans and improve patient survival rates.
Scientific Reports ( 2026 ) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in